Scanning Microscopy
Volume 7

Number 3

Article 29

6-14-1993

A Review of New Concepts in Renal Stone Research
L. C. Cao
Erasmus University and Academic Hospital

E. R. Boevé
Erasmus University and Academic Hospital

W. C. de Bruijn
Erasmus University

W. G. Robertson
King Faisal Specialist Hospital and Research Centre

F. H. Schröder
Erasmus University and Academic Hospital

Follow this and additional works at: https://digitalcommons.usu.edu/microscopy
Part of the Biology Commons

Recommended Citation
Cao, L. C.; Boevé, E. R.; de Bruijn, W. C.; Robertson, W. G.; and Schröder, F. H. (1993) "A Review of New
Concepts in Renal Stone Research," Scanning Microscopy: Vol. 7 : No. 3 , Article 29.
Available at: https://digitalcommons.usu.edu/microscopy/vol7/iss3/29

This Article is brought to you for free and open access by
the Western Dairy Center at DigitalCommons@USU. It
has been accepted for inclusion in Scanning Microscopy
by an authorized administrator of DigitalCommons@USU.
For more information, please contact
digitalcommons@usu.edu.

0891-7035/93$5.00+

Scanning Microscopy, Vol. 7, No. 3, 1993 (Pages 1049-1065)
Scanning Microscopy International, Chicago (AMF O'Hare), IL 60666 USA

.00

A REVIEW OF NEW CONCEPTS IN RENAL STONE RESEARCH
L.C. Cao*1, E.R. Boeve

1

,

W.C. de Bruijn 2 , W.G. Robertson

3

and P.H. Schr6der

1

1Department

of Urology, Erasmus University and Academic Hospital,
Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
2 AEM-Unit, Clinical Pathology Inst., Erasmus Univ., P.O.Box 1738, 3000 DR Rotterdam, The Netherlands
3Dept. Biol. & Med. Res., King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia
(Received for publication March 5, 1993, and in revised form June 14, 1993)

Abstract

Introduction

Clinical and basic research in the field of urolithiasis has developed rapidly in recent years. Progress
in extracorporeal shock wave lithotripsy (ESWL) and
percutaneous nephrolithotomy (PNL) has brought about
a revolution in the surgical treatment of urolithiasis and
research at the cellular and molecular level is now expanding. In spite of these advances, however, clinical
treatment of urolithiasis remains far from satisfactory.
Stone recurrence in many patients cannot be predicted
and is beyond control of urologists mainly because the
mechanisms of stone formation are still not fully understood. It is necessary to study the process of stoneformation more intensely at the cellular and molecular
level, and to strengthen the links between basic and
clinical research in the field.
In this review, the processes involved in the formation of stones are compared with those involved in
normal bio-mineralization and a model of urolithiasis is
put forward based on modern systems science. Attention
is concentrated on: (a) Directions of research based on
physico-chemical theories of stone formation; (b) The
role of renal tubular defects in urolithiasis;
(c) The
role of free radical reactions in stone formation; and
(d) Macromolecular abnormalities and their correction.

Although there has been considerable progress in
the field of urolithiasis research during the last decade,
the precise mechanism of stone formation is still obscure. It is necessary, therefore, to re-investigate the
processes of stone-formation at the cellular and molecular level. Within the same time scale, rapid developments have taken place in systems science. These developments have to be incorporated in the model of stoneformation.
In this review, new concepts in stone
research, such as systems science, will be introduced.
Bio-mineralization and urolithiasis
The concept that "urolithiasis can be considered
as a syndrome that is related to pathological bio-mineralization" has generally been accepted [80]. Bio-mineralization is the process that occurs in the body and results
in formation of bio-minerals. Because bio-minerals can
only be formed under physiological conditions, some
highly ordered structures and special means of organization are essential. Bio-mineralization is associated with
a series of specific properties and physiological functions (Table 1).
Bio-mineralization can be divided into two types:
(a) physiological mineralization (e.g., normally
growing bone, teeth and other hard tissues), and
(b) pathological mineralization.
There is a striking similarity in the chemistry between the two types of mineralization. The differences
between them lie in the sites where the processes take
place and in the degree of organization of the mineral
concerned. Various types of pathological mineralization
are listed in Table 2.
Demineralization is the opposite process to mineralization. From the viewpoint of chemistry, both mineralization and demineralization can occur simultaneously
and depend upon each other. From the viewpoint of
biology, mineralization and demineralization are both
"controlled" by cells. In this context, these are two aspects to "control": (1) the rate of the chemical reaction
is controlled by various kinetic factors, and (2) the equilibrium between mineralization and demineralization is
controlled by thermodynamic factors.
The introduction of the concept of bio-mineraliza-
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tion into the field of urolithiasis has necessitated taking
into account the following: the cellular metabolism, cellular activity, and the participation of macromolecules
and matrix in stone-formation.
Cells are considered to
provide the required micro-environment
and control for
conditions necessary for mineralization,
including synthesis and regulation of macromolecules
and matrix
materials.
Recently, Coe et al. [29) listed common
protein inhibitors of crystallization in various vertebrates
(Table 3). The authors proposed the idea that the problem of crystallization
and its modulation by inhibitors
has been a general problem for nature throughout evolution. Therefore, the concept of bio-mineralization
could
be useful in increasing our understanding of the mechanisms of stone-formation.

Table 1. The characteristics

of bio-mineralization.

Structure

High level of order in bio-minerals

Composition

Bio-minerals are formed in special media
and are embedded in an organic matrix.

Functions

The constituent ions of all bio-minerals
participate not only in the processes of
mineralization
and demineralization,
but
also in various cellular reactions.
Biominerals can only be formed during biological metabolism.

Information theory. Information can be defined
as a state and style of movement of an event. Information processing has to be controlled, irrespective
of
whether it happens between a human being and its natural environment or between cells and their surrounding
micro-environment.
The process of transforming information has a material base such as a message carrier,
transmission media, and receptors, etc. There is a relationship between the sequence of events and the information capacity: the larger the information content, the
higher the sequence. For example, the selectivity of an
enzyme for its substrate depends upon the size of the
molecule and its spatial configuration, the distribution of
the electron charge and its hydrophobic parameters. The
more specific an enzyme, the larger its information content. It should be emphasized that modulation of homeostasis can only be obtained when based on a highly ordered structure in the body, and that this modulation
possesses a material base.

Modern systems science in urolithiasis
The concept of "strong inference" as a strategy in
science was first introduced into stone research by
Finlayson [22]. To understand the mechanisms of stoneformation at the cellular and molecular level, it is necessary to introduce various elements of modern systems
science, namely: (1) system theory, (2) cybernetics,
(3) information theory, (4) bio-self-organization,
and
(S) non-equilibrium thermodynamics.
First, we would like to give a brief introduction
of several elements of system science; second, we will
try to establish a link between systems science and the
pathological process of urolithiasis; last, we will explain
the mechanisms of stone-formation
based on systems
science.

System theory. The human body may be considered to be a large system composed of many sub-systems
in which many complex reactions occur simultaneously
and depend on each other. Its main feature is that it
comprises an open reactive system that has to exchange
materials and energy between each sub-system and its
surrounding environment.
Compartmentalization
of the
human body includes a series of reactions which are
demonstrated in physiological and biochemical processes
as follows: (a) concentration of materials; (b) separation
of reactants; (c) changes in various equilibrium points
which depend on the concentration gradient of reactants
and other conditions; (d) changes in reaction velocity.

Bio-self-organization.
Bio-self-organization
is
the basis of the maintenance of biological systems.
Many human organs, tissues and cells exhibit this phenomenon, which guarantees the stability of each biological entity. Bio-self-organization
is the process of forming an orderly structure.
This can be considered to be
a very important
characteristic
of the biological
universe.
Non-equilibrium thermodynamics. The human
body can be thought of as a highly ordered structure being at a far from equilibrium state. Between this open
reactive system and its surrounding environment,
exchange takes place, not only of materials, but also of energy. Non-equilibrium thermodynamics studies the thermodynamic behaviour taking place tinder far from equilibrium conditions which can lead to the formation of a
dissipative structure that is stable, orderly and dynamic.
This occurs under the following conditions: (1) the system must be an open reactive system; (2) various elements within the system should have non-linear correlations; (3) when the system becomes unbalanced, a new
stable structure with orderly characteristics
is formed
through fluctuations of the system. It should be noted
that the dissipative structure is a living structure which
is quite different from an equilibrium death structure.

Cybernetics.

In cybernetics,
the relationship
between input and output, and various modulations of
these processes within a given system, are studied. The
majority of chemical reactions in the human body are
carried out under far from equilibrium conditions.
A
steady-state is established when input becomes equal to
output. However, the system must be controlled in order to establish homeostasis.
Modulation of these systems usually depends on a pair of antagonistic regulators
(promotory and inhibitory factors) or on an opposite direction for a process (change-over switch). It should be
emphasized that a non-equilibrium state can produce orderly structures in time (chemical vibration) and in space
(dissipation
structure and other sequence structures)
[90).
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Table 2. Various pathological bio-mineralization

processes.
Calculus

Tissue mineralization
(1) Calcification

(1) Dental calculi

of necrotic tissue

(2) Ectopic mineralization

(2) Gallstone, gastric and pancreatic calculi

(3) Crystal membranolysis

(3) Renal, ureteral and bladder calculi
Table 3. Known crystallization

Name
Nephrocalcin
Tamm-Horsfall

protein

Antifreeze protein
Statherin
Pancreatic stone protein
Gallstone protein
'G: Growth, N: Nucleation,

r:

Kidney/Urine
Kidney/Urine
Fish Blood
Saliva/Salivary

gland

Pancreas
Bile

Inhibition'

Target crystal

Location

Calcium oxalate

GIN/A

Calcium Oxalate

A

lee
Brushite/ Apatite
Calcite

N/G
N/G
N/G
N/G

Calcite

A: Aggregation.

set of "p" output signals (8) that can be described by
8 = I 8 1,8 2,8 3, ... ,8P I . Assuming that there is a
transition within the system from one internal state to
another, following a given input signal, the reaction
proceeds according to a set of well-defined rules:

F

F :0 x

inhibitions in vertebrates.

G

-+

0

e
URINARY
TRACT
svsTEM
8 : 0 x r: _ e

F:QxI:-+Q

(I)

where "x" indicates interaction, and F is a transition
function or a set of rules that pairs each member of set
Q x I: with one or more members of set Q. The system
generates an output signal whose character is determined
by its internal state according to the rule:

Figure 1. A response model of stone formation in the
urinary tract system in which I: = set of input signals;
Q = set of metabolic states; 0 = set of output signals;
F = state transition function; and G = output state function. According to this model, an abnormal output signal or state function demonstrated by an individual stone
former can be imagined from his initial metabolic state
of body and input signals from its surrounding environment. See text for details.

G:QxI:-+8

(2)

where G is the output function that pairs the internal
states plus received signals of the system with an output
signal. Above statements are schematically shown in
Fig. 1. It can be seen that the abnormal output signals
(8) (e.g., lower urinary inhibitory activity, hypercalciuria, hyperoxaluria, hyperuricosuria and hypocitraturia)
and the abnormal output state function (G) as revealed
by a dynamic procedure such as a calcium load test, indicate that there may be something wrong with the function of the urinary tract system (Q), and/or that the system cannot tolerate a strong stimulation of environment
factors (I:).
The application of systems science to stoneformation is summarized schematically in Fig. 2. Generally speaking, an input signal must be recognized first,
then the body can trigger the control-unit for response.
Thus, the body can remain in homeostasis during normal
physiological processes.
Homeostasis in human body
represents a metabolic state with a very low probability
value for stone-formation.

The modern concept of systems science can be included in our thinking about urolithiasis, in relation to
its initiation, progress, treatment and prevention.
We
can use systems science to answer the question: why do
some people suffer from urolithiasis while others, living
under the same conditions, do not?
Urolithiasis can be considered to result from an
alteration in the state functions. There is a set of state
functions representing a set of "n" metabolic states (Q)
in the urinary tract system which can be described by
Q = I q1,q2,q3, ... ,q 0 I - Thissystemcanrecognizeand
interact with a set of "m" input signals (I:) originating
from its environment which can be described by
I:=
I a1,a2,a3, ... ,am I . The system also produces a
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do not know where the initial site of formation of the
urinary crystals is: in urine itself, within the renal
tubular lumen or within renal tubular cells?
It has been demonstrated that a high percentage of
large crystals ( > 12 1-'m)is one of the characteristics of
recurrent Ca Ox urolithiasis [99]. The lack of an appropriate reaction against exogenous disturbances, such as
overloads of calcium, oxalate, acid, citrate, purine, and
protein, in stone-formers suggests defects in their control system in vivo [38, 52, 61, 62, 86, 105, 106]. An
epidemiological investigation has shown that stone-formers have a metabolic sensitivity to stimulation by the
diet [99]. This aspect of a body process "out of control"
may explain the existence of "injuries" to the urinary
tract. An "injury" to the organism can arise both at the
cellular and molecular levels. The same triggering factor may induce different pathological processes, depending on which sites and which target molecules are affected. Many abnormal phenomena, which are found in
stone formers, e.g., pathological alteration of renal
tubular cells, formation of Randall's plaques, alteration
of the properties of the urothelium, and the secretion of
abnormal macromolecular substances, might be attributed to the existence of injury to the renal epithelium.
According to the analysis of pathological processes of urolithiasis from the viewpoint of modern systems
science (see Figs. 1-2), it is easy to understand the directions for future research as proposed by the Consensus Development Conference on the Prevention and
Treatment of Kidney Stone [32].
Based on these
directions, the following questions should be addressed:
(a) What are the triggering factors which induce
stone-formation?
(b) How do these factors play a role in stoneformation?
(c) Where are the injuries located at the various
levels associated with stone formation? What is the molecular basis of injury?
(d) Can we recognize and correct the molecular
and cellular abnormalities to prevent stone formation and
its recurrence?
Recently, evidence has indicated that the early
events in the process of stone-formation occur in the
kidney. These include:
(a) Sites of initial stone/crystal formation and
their micro-environment [36];
(b) Injury of renal tubules and crystallization
occurring afterwards [60, 69];
(c) Abnormal properties of intrarenal macromolecular inhibitors and stone formation [4, 6, 29, 30, 37,
50, 116, 117];
(d) Abnormal transport of calcium and oxalate in
kidney tubular cells and its influence on stone-formation
[12, 21, 55, 72, 74];
(e) Interaction between crystals and cells, and the
mechanisms of crystal retention, especially investigation
of the principle of cellular modulation in stone-formation
[ 120];

(' AMPLIFY

HOMEOSTASI

TAIGG:AING
FA:TOAS
1•

{~
ENVIRONMENT

INJURY

UROLITHIASIS

REPAIR

Figure 2. General pathological model of urolithiasis
deduced by system science. From the viewpoint of system science, urolithiasis can be thought of as a kind of
disorder of regulation occurring between human body
and its surrounding environment.
Homeostasis represents a normal physiological regulation state which can
tolerate triggering factors from the environment and remain unchanged.
Once the homeostasis is interfered
with too strong triggering factors, human body is undergoing a over-control regulation resulting in "injuries" or
dysfunction. If the injuries cannot be repaired by the
system (human body), the pathological process of stone
formation will start. See text for details.
It should be emphasized that no "injury" to the
system occurs during normal physiological processes.
If there is mild "injury", it can be repaired by the body
itself. Once this regulatory repair ceases to function
properly, however, a persistent "injury" will take place.
When the injury cannot be repaired, the human body
system will enter into the pathological process known as
urolithiasis.
Unfortunately, in only approximately 20% of patients with calcium urolithiasis, an underlying metabolic
disorder or molecular defect can be diagnosed. For the
remaining 80% of the patients, they may have multiple
abnormalities including idiopathic hypercalciuria, hyperuricosuria, mild hyperoxaluria, and hypocitraturia which
often may be present with significant overlap of risk factors [113]. In these cases, a renal cellular defect in the
handling of calcium, uric acid, oxalate, and citrate
should be considered as possibly being responsible.
Normal subjects have a "perfect" bio-control
system. For example, crystal nucleation, which occurs
in highly supersaturated urine, seems to be a normal response of the body to an excess of solutes in urine.
Once a large amount of crystals precipitates in urine,
supersaturation decreases immediately. The speculation
that the nucleation rate, in up to 92 % fresh urines from
normal subjects, was higher than those from stone-formers, has recently been confirmed by Kavanagh [57] using a continuous crystallization system. This may explain why crystals can often be found in urines from normal subjects. The differences between urinary crystals
of stone-formers and normal subjects in size, composition and surface properties can be related to the processes of their formation in vivo. Unfortunately, we still
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(f) Effects of free-radical reactions occurring in
vivo on stone formation [94, 109-111, 118].

Physico-Chemical

fore, the change of entropy (dS) in the system will be
positive or negative depending on the value of dSe.
When dS is negative the total entropy of the system will
decrease with decreasing value of negative entropy current (dSe) and the system may constitute a dissipative
structure in which the system is transformed from a random to a non-random one, and form a high ordered
structure with low entropy.
The concept that a non-equilibrium state is the
origin of the sequence, has been recently recognized and
accepted [82, 83]. Some questions previously assumed
to be insoluble in the field of life sciences, such as biological evolution, self-catalysis, bio-self organization,
negative and positive feedback control (which cannot be
solved by classical thermodynamics) have been successfully explained [56].
To define the processes of stone-formation at the
molecular and cellular levels, it is essential to have a
model available. An attempt to incorporate the effects
of secretion, re-absorption and flow in the urinary tract
in a highly integrated computer-simulation strategy has
recently been published [22]. A molecular model of the
living cell, developed during Bhopalator (India) congress
in 1985, integrates molecular genetics, enzymology and
biochemistry within a coherent theoretical framework
[56]. It can be supposed that the Bhopalator cell model
may be useful for the later investigation of stone-formation. According to the Bhopalator model, the living cell
has to be considered as a self-moving, self-regulating
and self-reproducing machine that receives information
and energy from its environment, processes the information and generates output signals to the environment in
order to realize a teleonomically designed function [56].
Traditionally, one thinks that stones can be
formed in urine with high supersaturation and low inhibitory activity [97]. This speculation perhaps is partially
right, but the initial micro-environment might need a
special reaction medium and a matrix, and the influence
of a cellular metabolism. This environment is generally
ignored. For instance, it has been suggested that minerals and organic matrixes are both necessary for the
orderly structure observed in urinary calculi. However,
the following questions remain to be answered:
(a) Which component plays the decisive role in
stone formation: the minerals or the organic matrix?
(b) What is the ordering structure of a stone?
(c) How do the minerals and matrix cling
together?
It is necessary to study the mechanisms of stone
formation not only in simple inorganic solutions, but
also in complex physiological media such as whole
urine, cytosol and tissue fluid [91, 104]. In addition,
there is now more emphasis on the role played by tubular cells in stone-formation. There are several possible
roles:
(a) Cellular compartmentalization may provide
the required micro-environment for bio-mineralization;
(b) Cells may induce crystal nucleation on a
template by supplying growth sites for crystallization

Theory of Stone Research

The physico-chemical theory of stone research has
given the exact definition of the phases of stone-formation and has indicated the targets for the prevention of
stone formation and stone recurrence [40, 81, 85, 96].
In the past, it has been shown that many factors can play
a role in stone-formation by the means of thermodynamic and kinetic processes. Therefore, new data have to be
linked with this physico-chemical theory. However, to
explain the complex situation which exists in vivo, the
physico-chemical theory of stone formation needs to be
developed in two new directions:
(a) from the use of simple media (artificial or
diluted urine) to complex physiological media (whole
urine system, intracellular and extracellular fluid, and
bio-membranes); and
(b) from classical thermodynamics in a closed
system to non-equilibrium thermodynamics in an open
reactive system.
It may be necessary to explain why there should
be a development from the use of classical thermodynamics to non-equilibrium thermodynamics. This is logical, because stone-formation is the process of forming
bio-minerals, occurring under "far-from-equilibrium"
conditions in the body which itself is an open system.
Hence, application of non-equilibrium thermodynamics
in life sciences becomes more and more important.
Until now, no one has been able to produce in
vitro bio-minerals such as bone, teeth and renal stones,
that possess exactly the same features as their counterparts in vivo, in terms of composition and structure. A
satisfactory explanation of the fine structure of the biominerals can be made utilizing non-equilibrium thermodynamics, because a stable, orderly and dynamic structure can only arise by non-linear rising and falling in an
open system.
According to Prigogine's theory [82] of dissipative structure, the change of entropy (dS) in an open system can be divided into the following two parts:
(a) the change of entropy production (dSi) is due
to an irreversible process inside the system (e.g., heat
transfer, diffusion, chemical reaction etc.); and
(b) the change of entropy current (dSe) is due to
the exchange of materials and energy with the environment, that surrounds the system;
The total entropy change (dS) in the system is the
sum of dSi and dSe described as equation (3):
(3)

From the second law of thermodynamics we have,
for a non-equilibrium state:
(4)

but the value of dSe can be positive or negative, there-
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and by inhibiting crystal growth and aggregation by
secreting and regulating macromolecular substances and
matrix materials;
(c) Cells may create, through their metabolic
activity, the conditions that allow bio-mineralization to
take place in the cell-surroundings.

segment of the Renie's loop is the initial site of stoneformation. Recently, our ultrastructural study of experimentally induced microliths in rat was able to demonstrate not only ultrastructural changes in the proximal
tubular cell, but also showed the presence of intracellular crystals in more distal tubular cells, after 4 to 8 days
on the lithogenic diet [19).
It is known that a specific metabolic disorder cannot be found in 80 % of patients with idiopathic calcium
oxalate urolithiasis (ICU).
It is not yet clear as to
whether ICU is a specific disease or whether it is only
the expression of an intrinsic metabolic abnormality, and
is ICU a disease of renal cells or does it originate in the
urine? Should we switch our research efforts to the biology of tubular cells, or should we continue to address
the traditional stone-forming constituents of urine and
their physico-chemistry in order to understand the early
events of stone disease [107]? In this connection, the
following questions need to be answered [32]:
(a) What are the fundamental mechanisms of
ICU?
(b) Is renal tubular injury and/or dysfunction
involved in the pathogenesis of stones?
(c) Is there a genetic basis for ICU and can
individuals at risk of stones be identified using genetic
probes?
(d) For defined genetic disorders will gene
therapy have practical application?
In this connection, Bianchi et al. [17] found that
in erythrocyte membranes the calcium-magnesiumATPase activity was significantly increased in 38 patients with idiopathic hypercalciuria.
They suggested
that the abnormalities in erythrocyte calcium-magnesium-ATPase activity may represent an inherited defect in
calcium transport related to the cause of idiopathic
hypercalciuria.
Baggio et al. [11, 12] reported altered red blood
cell transmembrane transport of oxalate in "idiopathic"
renal stone formers, they found a higher-than-normal exchange rate in 78 % of patients. This observation has
since been confirmed by other groups [55, 74). However, Motola et al. [72] have recently shown that the abnormal values of oxalate self-exchange in erythrocytes
is not specific to patients with ICU but may be found in
patients with other renal diseases. However, Baggio insists that Motola's
observation does support his
hypothesis [43).
The defect in oxalate self-exchange in erythrocytes of patients with idiopathic calcium oxalate nephrolithiasis seems to lie in a Band 3 protein that controls
anion transport by phosphorylation and dephosphorylation [13, 14). Recently, Baggio et al. [15] reported that
oral administration of glycosaminoglycans (GAGs) significantly lowered both the rates of Band-3 phosphorylation and erythrocyte oxalate self-exchange, and reduced
urinary oxalate in 40 patients with idiopathic calciumoxalate nephrolithiasis.
The mechanism of action of
GAGs in correcting the abnormality in the erythrocytes
of patients with ICU seems to be through the inhibition

Renal Tubular Defects and Urolithiasis
The mechanism by which the initiation of calcium
oxalate stone occurs is not completely understood.
There are two main theories.
One theory states that
stone-formation is essentially an extracellular process.
When the renal tubular concentrations of calcium and
oxalate exceed the formation product of that salt, it
causes spontaneous crystallization of calcium oxalate
within the renal tubule. If within the transit time of
urine through the urinary tract, the resulting crystals and
aggregates grow sufficiently iarge to become trapped at
some narrow section of the tract, they may go on to
form stones [ 100]. The other theory states that it is an
intracellular process. Crystals are formed first within
the tubular cells and, if this is excessive, it leads to cell
death. The crystals and cell debris extruded from the
cell act as nuclei for renal stone-formation by blocking
the tubule [93]. Whichever theory is correct, the concept that a cellular metabolic defect in the handling of
inorganic ions and/or at in the synthesis of macromolecular substances is the basic problem in stone-formation
has generally been accepted [21, 30, 68]. The speculation that renal tubular injury induced by various agents
is the cause of urolithiasis has been supported by animal
investigation [19, 60), cell culture study [69] and
clinical observation [I I].
Calcium oxalate stones can be induced in animals
by the oral administration or injection of oxalate or one
of its precursors, with or without gentamicin, have been
indicated. In such models, renal tubular injury has been
detected [27, 58-60). The enhanced excretion of urinary
enzymes, including brush border enzymes (such as alkaline phosphatase, ,,-glutamyl transpeptidase and leucine
aminopeptidase) and lysosomal enzymes (such as N-acetyl-ll-glucosaminidase) during the first 24 hours of challenge, suggests that there may be damage to the brush
border membrane of the renal tubules and that this correlates with the retention and deposition of crystals in the
kidney [60), Ultrastructural studies have also demonstrated a relationship between crystal deposition and
damage to the tubular epithelium.
Crystal deposits,
formed as a result of hyperoxaluria, have always been
associated with degradation of the cell membrane. But
in these animal experiments, the following two questions
were not answered:
(a) Does the renal tubular injury precede or
follow the process of crystal formation?
(b) Is the initial crystal formation an intracellular
or an extracellular process?
Deganello et al. [36) reported that, according to
their micropuncture data, the tubular fluid in the thin
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of the protein kinase involved in Band-3 phosphorylation. This, in turn, leads to a lower transmembrane
oxalate transport.
Since red blood cells are good models for the
study of membrane function and transport systems, the
above results obtained from red blood cells could logically be extrapolated to other types of cells. If intestinal
absorption and renal oxalate secretion occur in a fashion
similar to that in red blood cells (via Band-3 or Band-3related proteins) then the relationship between the common cellular defect and the pathophysiology of idiopathic calcium oxalate nephrolithiasis may be defined.
New molecular and biological investigations in the field
of Band-3 protein and anion transporters will have to be
carried out in order to test the hypothesis that an inherited defect in the cellular transport of oxalate may be a
common factor in idiopathic calcium oxalate nephrolithiasis [21].
In order to elucidate the cellular
mechanisms underlying the cause of stone disease,
Sigmon et al. [114] studied oxalate uptake in suspensions of renal cortical and papillary cells derived from
control and stone-forming rats. They found that, in the
renal tubular cells from rats, in which stones were induced by administration of ammonium oxalate and gentamicin, there was reduced uptake of oxalate in cortical
cells and an enhanced uptake of oxalate in papillary cells
compared with the corresponding cells from untreated
control rats. This finding suggests that the alteration of
oxalate transport in damaged rat renal tubular cells may
play a role in the causation of their stones.
In summary, up to now, the fundamental mechanisms of ICU are not yet solved. Although it is not
clear yet whether or not there is a common defect in cellular calcium and/or oxalate transport in the patients
with ICU, further investigations of searching for any
possible genetic abnormality in these patients probably
are needed.

termination. Once a free radical reaction is induced in
cells, the reaction is not only fast, but it may also seriously damage cells. For example, lipid peroxidation occurring on the cellular membrane may disrupt the structural integrity of the lipid bilayer leading to increased
membrane permeability and subsequent impaired ion
transport, impaired electron transport for the oxidative
phosphorylation in mitochondria, and increased lysosomal permeability. Increased lysosomal permeability
causes the release of hydrolytic enzymes that further
enhance cell injury [44].
Recent evidence indicates that an oxygen and/or
hydroxyl radical reaction mechanism can injure renal tubular cells and promote calcium oxalate crystallization
within the cells [94]. Bakris et al. [16] reported that the
increase in urinary Tamm-Horsfall protein excretion after injection of contrast medium is, in part, mediated by
oxygen free radicals and may serve as a marker of renal
tubular injury. Walker and Shah found evidence for a
role of hydroxyl radical in gentamicin-induced acute
renal failure in rats [121]. Selvam and Kurien [109]
reported that oxalate can induce lipid peroxidation
through inhibition of catalase activity.
Lipid peroxidation of unsaturated fatty acids has
been linked with altered membrane structure and enzyme
inactivation which may lead to an oxidative cellular
damage [39]. Although it was known that deficiency of
vitamin B-6 results in increased oxalic acid biosynthesis
in liver and leads to hyperoxaluria, very little work has
been done on the implications of the hyperoxaluria induced by vitamin B-6 on lipid peroxidation in subcellular
fraction of the rat kidney. Recently, the results presented by Ravichandran and Selvam [94] indicated that
calcium and oxalate accumulate predominantly in the
subcellular fraction of the kidney, and that these membranes-like materials may be the site for stone-formation
through peroxidative damage.
More recently Selvam and Devaraj [110] have examined the effect of lipid peroxidation on oxalate binding in mitochondria. Their finding is that lipid peroxidation, via the hydroxyl radical reaction, led to oxalate
binding in rat kidney mitochondria. Therefore, it can be
reasoned that the accumulated oxalate, derived from the
enhanced oxalate binding reaction under the condition of
increased peroxidase activity, may be an important factor for the aetiology of stone formation.
Erythrocyte lipid peroxidation has been found to
be elevated in kidney stone patients [3]. Taking into account the fact that the flux rate of erythrocyte oxalate
self-exchange is abnormally high in the patients with
idiopathic urolithiasis [10], one may speculate that the
elevated lipid peroxidation, resulting in injury of the
membrane, may be responsible for this finding.
Increasing evidence regarding the role of free radical reactions in the causation of stone-formation suggests that the effects of free radical reactions on oxalate
binding, on macromolecular substances secretion and on
the oxalate transport should be explored in model systems, both in vitro and in vivo. A new investigation of

Free Radical Reaction in Stone Research
A marked increase in interest in the role of free
radicals in biology and medicine has developed during
the last 20 years [42, 47]. (A free radical is an atom or
molecule with one or more unpaired electrons in the
outer orbit such as -0 2-, and ·OH).
Many free
radicals can be detected using an electron paramagnetic
resonance spectrum analyzer.
A multitude of endogenous and exogenous sources
of free radicals exist. Exogenous sources include oxidative drugs (such as CCl 4 and acetaminophen), cigarette
smoke, radiation and substances that oxidize glutathione.
Considering the situation in vivo, cellular sources include the mitochondrial electron transport chain, the microsomal electron transport chain, oxidation enzymes
(such as xanthine oxidase and cyclooxygenase), phagocytes, and cellular auto-oxidation of Fe 2 + and epinephrine [42].
In general, in a free radical reaction, the following three steps are present: induction ➔ propagation ➔
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Table 4. Various macromolecular abnormalities in urolithiasis.
Abnormality•

Name

Effects on urolithiasis

Enzyme disorders
Alanine:glyoxylate aminotransferase
D-glycerate dehydrogenase
Xanthine oxidase
Ribose phosphate pyrophosphokinase
Hypoxanthine phosphoribosyl transferase
Adenine phosphoribosyl transferase

Deficiency
Deficiency
Deficiency
Superreactivity
Deficiency
Deficiency

Type-I Hyperoxaluria
Type-II Hyperoxaluria
Urolithiasis (Xanthine)
Urolithiasis (Uric acid)
Urolithiasis (Uric acid)
2,8-Dihydroxydeninuria

Deficiency or abnormal structure
Abnormal existing state
Deficiency, Structure
and Composition
Deficiency or others
Unknown
Unknown
Unknown
Abnormal structure or composition

CGI and CAI**
CGI and CAI
CGI and CAI; antiadherence of crystals
CGI and CAI
CGI and CAI
CGI and CAI
CGI and CAI
CGI and CAI

Structure

Oxalate transport

Inhibitors
Nephrocalcin
Tamm-Horsfall protein
Glycosaminoglycans Heparan sulphate and
Chondroitin sulphate
Ribonucleic acid (RNA)
Uropontin
Crystal matrix protein
Inter-a-trypsin protein
Water surrounding macromolecules in kidney

Anion exchanger
Band-3 protein

*The abnormalities of enzyme, inhibitors and anion exchanger reflect metabolic disorders and cellular injuries or dysfunctions in patients with urolithiasis.
**cGI: inhibition of crystal growth;
CAI: Inhibition of crystal aggregation.

Nephrocalcin
Nephrocalcin is a glycoprotein isolated and purified by Nakagawa et al. [75, 79]. The nephrocalcin in
urine is a macromolecular complex with molecular
weight (MW) from 14 to above 200 kD. Cell culture
and immunohistochemical examination have indicated
that nephrocalcin is present in renal proximal tubular
cells and in the thick ascending limb of Henle's loop
(TAL) [76, 115].
It is well known that normal nephrocalcin not only
inhibits the growth of calcium oxalate crystals, but also
the aggregation of such crystals which is a most important risk factor for stone-formation [48, 78, 125].
Nephrocalcin can be adsorbed to calcium oxalate crystals
forming a monomolecular layer which inhibits crystal
growth. As nephrocalcin is a metabolic product of renal
cells, defects in the molecular structure of nephrocalcin
and a pathophysiological disorder may be responsible for
stone formation.
An investigation of the interaction
between a cultured cell line of monkey kidney cells and

the mechanisms of a free radical reaction in stone formation [111] and an application of a free radical scavenger
such as DL a-lipoic acid in stone prevention has more
recently been reported [118].

Macromolecular Abnormalities and
Their Correction in Urolithiasis
Recently, investigators have concentrated on trying to determine the macromolecular abnormalities associated with urolithiasis and on looking for approaches to
correct them. Modern molecular biological techniques
are available to clarify the relationship between abnormal macromolecular substances and stone formation.
Probably gene therapy of stone disease can be expected
in the future. Various macromolecular abnormalities in
urolithiasis are summarized in Table 4. Because the
listed molecular pathophysiological mechanisms of the
enzyme disorders have been clarified, here we will only
discuss the following abnormalities of macromolecules:

1056

New concepts in renal stone research
may be many immunomodulatory roles for THP [33, 53,
123].
Based on THP/uromodulin synthesis, localization
and molecular structure, this glycoprotein may play the
following roles in calcium oxalate urolithiasis:
(a) THP may be considered as a intranephronic
inhibitor of crystal growth and agglomeration.
It
prevents large crystal formation under physiological
conditions [30, 108].
(b) Specific intranephronal pathological conditions, such as low pH, high ionic strength, high concentration of sodium and calcium and presence of oxygen
free radicals, can stimulate THP self-polymerization in
tubules. As a result, THP may be considered as a promoter of stone formation [103].
(c) According to the protective colloidal theory
of stone formation [23], THP in normal urine could be
bound to crystal surfaces as a stabilizing agent for the
urinary colloidal system through a steric stabilization
mechanism. Thus, THP can be considered as an inhibitor of stone-formation.
(d) Depending upon the urinary environment,
THP in urine may exist in different forms. Non-polymerized THP can be considered as an inhibitor of crystallization; whereas polymerized THP is a promoter [18,
108].
(e) Since mannose-sensitive fimbriated bacteria
such as E. coli adhere to THP via mannose-containing
side chains, it has been suggested that THP may trap urinary pathogens and prevent them from cloning the urothelium [84]. This mechanism ofTHP may be beneficial
for the prevention of stone-formation and stone recurrence.
(I) A free radical reaction may occur in the
kidney to induce stone formation, in which intranephronal THP could be polymerized and denatured in
a very fast reaction [ 16].
Although many studies have been carried out on
THP/uromodulin
gene analysis, molecular structure
analysis, immunological characterization and its corresponding physiological functions, we still do not know
what is the exact nature of THP from patients with calcium oxalate urolithiasis either in molecular structure of
THP or in its function. It has been shown in several studies that THP from stone formers, at low pH in the presence of NaCl and calcium, exhibits an increased tendency towards self-aggregation which reduces its ability to
interact with crystals and prevent their aggregation [18,
50]. The tendency may be inheritable, but the molecular
basis for the effect is unknown. Further investigation of
the molecular defects in THP from patients with urolithiasis may be an important direction for stone research.

calcium oxalate monohydrate (COM) crystals has been
done by Lieske et al. [65] who found evidence that
nephrocalcin can block the initiated DNA synthesis
induced by COM crystals stimulation.
Patients who form kidney stones, are claimed to
produce an abnormal nephrocalcin with a very weak inhibitory activity towards calcium oxalate crystallization
[77]. The main molecular abnormality of nephrocalcin
from patients with calcium oxalate nephrolithiasis is said
to be a deficiency in -y-carboxyglutamic acid (Gla). Because Gia in nephrocalcin commonly stabilizes molecules
into their final configurations through calcium bridges,
loss of Gla leads to reduction of inhibitory activity of
nephrocalcin and to loss of its amphilicity [77, 78].
However, later data do not support the finding [Netzer
et al. (1992) and Hughes et al. (1992); abstracts at the
VIIth International Symposium on Urolithiasis, Cairns].
Recently some new non-nephrocalcin inhibitors of
crystallization including uropontin [116], crystal matrix
protein (CMP) [37], Inter-a-trypsin protein [117], and
an other, unnamed, glycoprotein [4] have been demonstrated. These inhibitors are listed in Table 4.
Tamm-Horsfall

protein/Uromodulin
Tamm-Horsfall protein (THP) isolated from human urine by salt precipitation method [119] and uromodulin isolated from urine of pregnant women by lectin
adherence columns [73] are the most abundant proteins
in normal human urine, although THP and uromodulin
may be different names for the same protein since the
sequence of cDNA and the amino acids of uromodulin
has recently been shown to be identical to THP [53, 89].
The physico-chemical and biological properties of THP
have been studied extensively, but its function in various
pathological and physiological processes remains obscure [54, 102]. Rindler et al. [95] have used cDNA encoding for THP/uromodulin to study the release of the
expressed protein from cultured cells. Their results indicate that THP is one member of lipid-like membrane
proteins and is released into the urine after the loss of its
hydrophobic anchor, probably by the action of a phospholipase or a protease. Two excellent reviews have recently been published on this topic: one provides background data on the synthesis of THP/uromodulin and on
its location and properties [63], the second reviews the
roles of THP in calcium oxalate monohydrate crystallization [49].
THP/uromodulin is a major and specific renal
glycoprotein which readily polymerizes to form a gel
under conditions of low pH, high ionic strength and the
presence of certain mono- and divalent ions. It is synthesized by the kidney and localized in the epithelial
cells of the thick ascending limb 2(T AL) of Henle' s loop
and of early distal convoluted tubules [64, 112]. THP/
uromodulin is released into urine in large quantities in
a polymeric form (MW = 7x10 7 Da). Nuclear magnetic
resonance
(NMR)
data and available
molecular
biological evidence suggest the presence of a single THP
gene and multiple lectin binding sites in the tetraantennary chain of THP, which further suggest that there

Glycosaminoglycans

Glycosaminoglycans

1

(GAGs) are polysaccharide

1In literature,
some confusion exits about GAGs and
polysaccharides.
Some semi-synthetic polysaccharides
such as sodium petosan polysulphate are not real GAGs,
they should be named sulphated polysaccharides.
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chains composed of repeating disaccharides of identical
composition. GAGs including heparan sulphate, chondroitin sulphate, dermatan sulphate and hyaluronic acid
are naturally occurring in human urine. GAGs may be
present in urine in a free form or in association with
proteins, such as glycoproteins. Little is known about
the mechanisms involved in the synthesis and excretion
of GAGs in man. Although the differences of urinary
GAGs in quality or quantity between patients with urolithiasis and normals are not clear yet, there is no doubt
that GAGs and a number of semi-synthetic sulphated
polysaccharides can modulate calcium oxalate crystallization as is shown in various model systems in vitro and
in vivo [26, 51]. The following mechanisms of action of
GAGs in calcium oxalate stone prevention:
(a) GA Gs can act as inhibitors of calcium oxalate
crystal growth and aggregation in vitro [26, 34);
(b) GAGs act as protectors of the urinary tract
mucosa and can prevent crystal adherence to the mucosa
[45, 88, 120];
(c) GAGs can correct oxalate transport disorders
occurring at cellular membranes [15, 21];
(d) GAGs can modify the micro-environment
within cells and in urine to prevent stone-formation [25].
It should be noted, however, from a recent study
in rats that chondroitin sulphate promotes the growth of
stones in the urinary tract [71]. This finding suggests
that there is a complex situation in the mechanism of action of both endogenous GA Gs and exogenous sulphated
polysaccharides in stone formation. Investigations of the
mechanisms by which GAGs prevent stone-formation
should not be restricted to urines. The correlation between active stone formation and GAGs behaviour in cell
should be an important project. Many receptors for sulphated polysaccharides (GAGs) on lymphocytes as well
as on other cell types such as macrophages, polymerpronuclear leukocytes, mast cells and fibroblasts, have
been demonstrated by Chong and Parish [28) and Parish
and Snowder [87). Their studies illustrated that a variety of cell types and cell lines are able to bind certain
sulphated GAGs selectively. Clearly, biochemical characterization of these receptor molecules is important for
a better understanding of the mechanisms of stone-formation at the cellular level.
Baggio et al. [15] found that GAGs inhibit the
phosphorylation of Band-3 protein that may be responsible for oxalate transport. Oral GA Gs can correct the abnormality of red blood cell oxalate self-exchange rate
and reduce urinary oxalate excretion in patients with
idiopathic calcium nephrolithiasis.
In spite of the possible protective effects of GA Gs
against stone-formation shown in recent experimental results, the possible role for the accumulation of GA Gs in
stone matrix has to be investigated. It is possible that
molecular defects of GAGs caused by abnormal cellular
metabolism, have some connection to stone formation.
Water-surrounded macromolecules in kidney

late the specific pathophysiological and biochemical
characteristics of the stone forming environment [6-8).
In these studies, proton-relaxation time measurements
were performed on lyophilized urine samples collected
from recurrent calcium oxalate stone formers (SF) and
normal subjects (N). 1H- and 2 H-nuclear relaxation times
(T 1, T2) which change during rehydration of various
lyophilized urines, were measured using NMR. The
prolongation of the relaxation times as a function of
rehydration was found to differ significantly between SF
and N (P < 0.005). Water compartmentalization was
calculated according to a fast proton diffusion model.
Throughout
most of the rehydration
process,
significantly less water (P < 0.001) was bound to the
compounds of urine from SF than that obtained from
normal subjects.
These results suggest that the
macromolecules in the urine of calcium oxalate stoneformers and normals differ in their amount of water
binding sites and in the water multilayer thickness
surrounding them. Hydrophilic compounds, with a relatively large active surface area, seem to be characteristic
of the urine of normal individuals. Azoury's results [68] obtained from Iyophilized urinary compounds by
NMR are similar to those of Nakagawa et al. [78) who
reported that an important feature of the nephrocalcin
from patients with urolithiasis is the loss of its
amphilicity, which indicates less separated and wellorganized hydrophilic and hydrophobic sites.
Band-3 and related protein
Increasing evidence indicates that a high concentration of oxalate is a more important risk factor for
stone-formation than hypercalciuria [41, IOI]. Williams
and Wandzilak [124] reviewed the mechanisms involved
in the synthesis, absorption, excretion, and transport of
oxalate and the factors controlling these processes in
man, and gave background data on the clinical syndromes associated with hyperoxaluria and recurrent calcium oxalate stone disease.
In recent years, the possibility that some patients
with urolithiasis have a generalized oxalate transport abnormality, has attracted the attention of investigators
[11-15, 17, 21). Band-3 protein is a specific anion
transporter which is initially found located on the membrane of red blood cells [5, 24, 31). It is well known
that Band-3 protein is a 911 amino acid protein, and its
corresponding gene is located on chromosome 17 [67).
The carboxyl-terminal domain in Band-3 protein is a hydrophobic transmembrane domain to serve the anion
transport by phosphorylation and dephosphorylation
[20). Searching for Band-3 and related proteins in nonerythroid cells and other tissue may confirm the concept
that a defect in cellular oxalate transport is the fundamental abnormality in idiopathic calcium oxalate nephrolithiasis. Once it is identified that the defect of oxalate
transport in the kidney and the gut is similar to that in
red blood cells, a logical speculation can be made that if
there is something wrong with Band-3 in red blood cell
it will be the same for other anion exchangers. Increasing evidence indicates that many anion-exchangers share

A new approach, at the molecular level, to the understanding of the processes of stone-formation is to iso-
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functional similarities with Band-3 protein.
Selected
Band-3 proteins related to anion transporters of renal
epithelia are listed by Alper [l] in which MCT (medullary collecting tubule), CCT (cortical collecting tubule),
CTALH (cortical thick ascending limb of Henle),
MTALH (medullary thick ascending limb of Henle), PST
(proximal straight tubule), PT (proximal tubule), BBMV
(brush border membrane vesicles of proximal tubule),
and BLMV (basolateral membrane vesicles of proximal
tubule), LLC-PK I and MDCK are involved. A supposed
mechanism of oxalate secretion by the renal proximal
renal tubule is illustrated in Figure 3 [46] which has
recently been confirmed by the new result obtained from
LLC-PKl cell line [70].
Although human erythrocyte Band-3 is encoded by
a single-copy gene [67], and is expressed only by erythrocytes and by a subpopulation of acid-secreting cells in
the distal nephron [35] where no oxalate transport occurs, immunological evidence indicates that the genes
encoding Band-3 protein of the kidney and the intestine
belong to the same family. Anion exchange in nonerythroid cells may be mediated by closely related
molecules.
In our stone research laboratory, a new cell culture model has been set up for studying epithelial handling of oxalate and cellular interactions with crystals of

stone salts. In the model system, renal epithelial cells
cultured in two-compartment Transwell cell culture
chambers on collagen-coated permeable supports form
highly differentiated polarized monolayers resembling
naturally occurring epithelium. Our preliminary result
did not demonstrate a significant transcellular transport
in LLC-PKl cell line under the physiological conditions
used [ 120]. However, oxalate transport across the same
monolayer of renal proximal tubular epithelial cells
(LLC-PKl) as we used, has been shown by several research groups [70, 122]. This phenomenon may have
something to do with the following points: (a) The characteristics of anion transport in LLC-PK 1 cells may have
been lost; (b) extracellular environment including used
buffers, temperature, pH and concentration of chloride,
sulphate and bicarbonate; (c) the state of LLC-PKl cells
in these experiments; and (d) individual operation program in these experiments. We are now trying to search
for cellular oxalate transport in a primary cultures of
human renal proximal tubule in our cell culture model.
We believe that a molecular biological approach
will provide a powerful complement to immunological
and ligand-based methods for describing a class of the
anion transport proteins of renal and other epithelia,
which would be useful for stone prevention.
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Oxalate degrading enzymes

Conclusions

The concept that urinary oxalate is the most important risk factor in patients with calcium oxalate urolithiasis has been generally accepted. Thus, a logical
topic for stone research should be to develop effective
and safe methods for lowering urinary oxalate, regardless of the specific aetiology of stone disease. Many
approaches which may lower urinary oxalate include inhibiting oxalate synthesis in liver and kidney, blocking
oxalate secretion into the renal proximal tubule, and decreasing its absorption in the gut. Allison [2] has put
forward the idea that urinary oxalate may be lowered by
using oxalate-degrading enzymes in the gut. This suggestion is based on the fact that sheep fed with oxalaterich plants, in presence of sufficient numbers of degrading oxalate bacteria in their rumen (e.g., Oxalobacter
formigenes) are able to tolerate increased amounts of
oxalate without forming calcium oxalate stones.
Although mammalian cells do not produce any enzymes that are capable of degrading oxalate, two major
pathways for the degradation of oxalate in non-mammalian systems are: oxalate oxidase (EC 1.2.3.4) and
oxalate decarboxylase (EC 4.1.1.2). Recently two coenzymes (formyl-CoA-transferase
(EC 2.8.3.4)
and
Oxalyl-CoA-decarboxylase (EC 4.1.1. 8) participating in
biochemical pathways of oxalate degradation in oxalobacter have been purified and identified [9, 10]. It is
obvious that the applications of these enzymes may contribute towards reducing the circulating oxalate levels in
vivo. Such treatment could be beneficial for prevention
of calcium oxalate stone disease. An early example of
application of oxalate degrading enzyme in vivo has been
reported by Raghavan and Tarachand [92], who gave
rats oxalate oxidase plus peroxidase, loaded in dialysis
membranes, by intraperitoneal implantation. In recent
years, rapid developments of drug delivering techniques
such as liposome formation, erythrocyte loading or conjugating with poly ethylene glycol (PEG), can be expected for the therapy of these oxalate-degrading enzymes.
Based on modern molecular biological concepts, an innovative proposal to transfer the gene of an oxalate-degrading enzyme into human cells has been put forward.
This might be an extremely effective procedure for reducing the amount of oxalate in the body and in urine
but it is a difficult and dangerous technique. Recently,
cloning of the oxalyl-CoA decarboxylase gene from the
bacterium Oxalobacter formigenes and its subsequent expression in a foreign environment has been demonstrated
by Lung et al. [66].
Concerning the correlation of abnormal macromolecular substances (MMS) to urolithiasis, in general,
isolation, purification and identification of the MMS is
an important topic in the field of stone research.
Searching for exact defects of the MMS in stone formers
could be the first step to understanding the mechanisms
of stone formation. In addition, it should not be forgotten that existing state of the MMS isolated and their
properties may or may not represent the actual situation
in vivo.

In summary, the clinical treatment of urolithiasis
is still unsatisfactory, in spite of the technological advances brought by extracorporeal shock wave lithotripsy
(ESWL) and endoscopic surgery. But why has so little
progress been achieved in the field of stone prevention?
Perhaps, the old concepts on stone-formation need to be
challenged and a fresh approach to the problem introduced. In this paper, we have attempted to do this by
considering stone-formations a form of bio-mineralization subject to the laws of non-equilibrium thermodynamics and systems science. We firmly believe that the
processes involved in the formation of stones need to be
studied at the molecular and cellular level and that there
needs to be a strengthening of the links between basic
and clinical research in the field.
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Discussion with Reviewers
H.-G. Tiselius: Oxalate is undoubtedly a very powerful
urinary constitute in terms of calcium oxalate crystallization. Which limit of normal oxalate excretion is applied by the authors and according to your experience
how great is the fraction of stone formers that demonstrate a hyperoxaluria?
Authors: According to the critical value for defining
hyperoxaluria ( > 0.45 mmol of oxalate excreted within
24-hour urine), approximately 20-25 per cent of the patients with calcium urolithiasis were found as hyperoxaluria in our hospital. Due to the limitation of precise
analytical methods of oxalate in urine and serum/plasm,
no systematic metabolic evaluation of hyperoxaluria has
carried out in our hospital so far. Therefore, we just
follow the common formula to treatment of the stone patients with hyperoxaluria. However, we would like to
emphasize here the following points:
(a). A systematic evaluation for hyperoxaluria,
for instance, as Hatch recently described (Urol Res 21:
55-59, 1993), is clearly needed not only for further understanding the pathophysiological of hyperoxaluria, but
also for successful treatment.
(b). Although many methods to reduce urinary
oxalate can be chosen as listed in your review (Mineral
Electrolyte Metab 13: 242-250, 1987), best treatment for
individual patients with hyperoxaluria should be in accordance with the classification of hyperoxaluria.
Recently, a new classification of hyperoxaluria has been reported in which the term "mild metabolic hyperoxaluria"
was much improved (Urol Res 21: 55-59, 1993).
(c). Endogenous production of oxalate contributes to the hyperoxaluria, therefore, finding a way that
could significantly reduce endogenous production of
oxalate may an important topic.
(d). A link between hyperoxaluria and its molecular and cellular basis should be made in further
research.
(e). The viewpoint of system science described in
the present review paper is certainly needed in the research on hyperoxaluria. For example, Prof. Dr. Rose
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recently showed that excreted oxalate in plasma and 24hour urine significantly decreases with oral pyridoxine
in normal subjects, but does not in idiopathic stone formers with hyperoxaluria (Urol Res 18: 393-396, 1990).
This result may reveal a disturbance of system regulation
existing in patients which could be connected to a injury/
dysfunction of renal tubular cells.

The differences of chemical composition and
structures shown in a giving stone may have something
to do with the kinetic process of its formation and with
disturbances of the patient with urolithiasis. Therefore,
studying stone composition and structure may be beneficial for understanding the mechanisms of stone formation.

H.-G. Tiselius: Although most calcium stones contain
calcium oxalate, a significant number of these stones
also contain calcium phosphate. Do you have any speculation on the role the latter salt plays in these stones?
Authors: This is an interesting question, and also difficult to be answered in a brief way. The concept that
urolithiasis is a heterogeneous disorder, with varying
chemical composition and pathophysiologic background
has generally been accepted. Therefore, It is no surprise
to see the phenomenon that calcium phosphate can often
be found in calcium oxalate stones. The following speculations are listed for discussion:
(a). According to chemical characteristics of the
calcium ion, calcium is one of the most active and rich
divalent elements in vivo which can easily form insulated
salts either in physiological bio-mineralization (e.g.,
bone, teeth and other hard tissues) or in numerous pathological bio-mineralizations (e.g., urinary tract stones and
dentinal stones). Calcium ions can easily connect to oxygen atoms proved by a number of amino acids of protein, phosphoproteins and phospholipids.
In addition,
calcium ions can combine with polysaccharides and glycoprotein to form stable macromolecules.
All those
macromolecules containing calcium have biochemical
and physiological activity and certain functions in vivo.
(b). From the urinary chemistry, human urine is
supersaturated for a number of calcium phosphates including hydroxy apatite (HAP), octacalcium phosphate
(OCP), and di-calcium phosphate dihydrate (DCPD).
(c). From the physicochemical viewpoint of stone
formation, it is well known that calcium oxalate monohydrate (COM) can precipitate on the surface of seed
crystal of DCPD and HAP and that calcium oxalate trihydrate (COT) can induce crystallization of HAP at low
levels of supersaturation and HAP was a suitable seed
for further COM grow. In addition, stone matrix made
by dysfunctional renal tubular cells can combine with
HAP as a HAP-sphere that can induce COM heterogeneous nucleation.

H.-G. Tiselius: It is an interesting idea that crystals
form within the cell, from which they subsequently are
expelled or released. Would you consider it reasonable
to assume such a mechanism even for the crystalluria observed in normal subjects.
Authors: Recently the finding of intracellular crystals
has been shown in an ultrastructural study of experimentally induced microliths in rat proximal and distal tubules (J Urol 149: 893-899, 1993). Our results strongly
suggest that renal tubular cells are the host in stone
formation as a pathological bio-mineralization which
should be responsible for all earlier events of nephrolithiasis. However, it remains uncertain which process
is the first: luminal crystals or intracellular crystals?
intracellular changes or intraeellular crystals? Therefore, at this moment we can hardly imagine the behavior
of intracellular crystals such as their expelling or
releasing.
From the viewpoint of systems science and biomineralization, the crystalluria observed in normal subjects can be thought of as the result of a physiological
regulation against interference with an excess high concentration of stone salts in the urinary system. Crystalluria seen in normal subjects also reflects injury/dysfunction of the renal tubular cells, whereas a series of
abnormalities including renal handling ions, renal secretion modifiers of crystallization and epithelium properties will happen resulting in stone formation. Therefore,
crystalluria can be considered as a mirror of the environment where crystals and stones are formed.
J.P. Kavanagh: Has the use of system science given
you new insights into problems of urolithiasis and do
you think it will help in the future as greater understanding of stone formation at the molecular level
develops?
Authors: The answer should be "yes". This review
paper represents our own thinking on current stone research.
System science as a tool and a strategy in
urolithiasis research has been introduced by Prof.
Finlayson about 20 years ago [41]. In fact, many applied methods and achieved results in stone research are
more or less connected with the theory. You yourself
have also applied this viewpoint to explain the high
crystal nucleation rate you found in normal subjects
[57]. Each investigator should have the systematic viewpoint when he performs his study. Many examples have
been presented in our manuscript above.

(d). From the viewpoint of crystal retention, i.e.,
the interaction between cell and crystal, glycoprotein, an
important component of the cellular membrane, presumably has only two kinds of binding sites for accepting
calcium or phosphate, but none for oxalate. Oxalate
presumably combines with the glycoprotein through a
phosphate bridge.
In addition, phosphoproteins and
phospholipids located on renal tubular cellular membranes may provide the sites for combining calcium
which means these macromolecules provide a connection
between a crystal/stone and tissue.

1065

